Tapinarof Completed Phase 1 Trials for Psoriasis Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01984775A Study to Evaluate the Irritation Potential of GSK2894512 Cream on Skin in Healthy Subjects